CoreCap Advisors, LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1902501 SOUTHFIELD, MI

Position in ANIX

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$145,656

+$11,445 QoQ

Shares Held

52,020

0.0% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#14

of 62 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CoreCap Advisors, LLC holds $2,312,000 across 78 Biotechnology names. ANIX ranks #7 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	6,755	$367,539
2	MRNA	Moderna, Inc.	4,595	$321,787
3	ARWR	Arrowhead Pharmaceuticals, Inc.	3,000	$244,530
4	VRTX	Vertex Pharmaceuticals Inc / Ma	442	$219,554
5	REGN	Regeneron Pharmaceuticals, Inc.	315	$196,415
6	MDGL	Madrigal Pharmaceuticals, Inc.	280	$150,346
7	ANIX	Anixa Biosciences Inc This page	52,020	$145,656
8	LGND	Ligand Pharmaceuticals Inc	428	$135,286

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$145,656	52,020	0.0%	Shares	Sole	2026-07-06
2026-03-31	$134,211	52,020	+8.3%	Shares	Sole	2026-04-07
2025-12-31	$149,869	48,035	+2.7%	Shares	Sole	2026-01-13
2025-09-30	$154,397	46,787	0.0%	Shares	Sole	2025-10-22
2025-06-30	$154,397	46,787	+4.5%	Shares	Sole	2025-08-14
2025-03-31	$128,090	44,787	0.0%	Shares	Sole	2025-05-09
2024-12-31	$103,905	44,787	0.0%	Shares	Sole	2025-02-14
2024-09-30	$141,079	44,787	-4.5%	Shares	Sole	2024-11-08
2024-06-30	$103,635	46,894	+5.9%	Shares	Sole	2024-08-08
2024-03-31	$138,197	44,294	+22.3%	Shares	Sole	2024-08-08
2022-12-31	$153,888	36,209	-3.1%	Shares	Sole	2023-02-10
2022-09-30	$183,939	37,386	+0.7%	Shares	Sole	2023-02-10
2022-06-30	$113,636	37,136	-1.3%	Shares	Sole	2022-08-11
2022-03-31	$103,067	37,616	+7.6%	Shares	Sole	2022-04-29
2021-12-31	$103,807	34,952	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.